Researchers at Hospital for Special Surgery (HSS) have pinpointed a cellular target that could enhance the way osteoporosis and other metabolic bone diseases are diagnosed and treated. The findings, published recently in JCI Insight, reveal that …

Hospital for Special Surgery’s. Kyung-Hyun Park-Min, Ph.D., Lead Researcher, was published in Cellular & Molecular Immunology for her team’s work in identifying human osteoclast-specific signatures as new therapeutic targets for Antisense Oligo …